Results 1 to 10 of about 1,749 (172)
Use of Moisturizers and Lubricants for Vulvovaginal Atrophy [PDF]
Frontiers in Reproductive Health, 2021 The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect the quality of life of these women, principally those who are sexually active.
Ayane Cristine Alves Sarmento +5 more
europepmc +5 more sources
Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy [PDF]
MedicinaBackground and Objectives: Postmenopausal vaginal discomfort is often attributed to vulvovaginal atrophy (VVA). Women with VVA experience symptoms such as vaginal dryness, itching, burning, irritation, and dyspareunia. Materials and Methods: This pilot study was conducted to assess the effects of a micro-ablative fractional CO2 laser on the clinical ...
Svetlana Janković +5 more
europepmc +5 more sources
Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy [PDF]
Journal of Menopausal Medicine, 2017 Ospemifene-a third-generation selective estrogen receptor modulator approved by the Food and Drug Administration in 2013-is an oral medication for the treatment of dyspareunia. In postmenopausal women with vulvovaginal atrophy, ospemifene significantly improves the structure and pH levels of the vagina, reducing dyspareunia.
Jae Jun Shin +3 more
europepmc +5 more sources
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy [PDF]
Frontiers in Reproductive Health, 2021 Menopause is a physiological and progressive phenomenon secondary to decreased ovarian follicular reserve that significantly affects the genital tract. Although postmenopausal vulvovaginal atrophy primarily affects postmenopausal women, it is also seen in premenopausal women. The hypoestrogenic condition results in hormonal and anatomical changes, with
Ana Paula Ferreira Costa +7 more
openaire +4 more sources
Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception [PDF]
Gynecological Endocrinology, 2023 The objective is to assess the perception of gynecologists regarding patients' adherence to vulvovaginal atrophy (VVA) treatments, to evaluate the gynecologists' opinions on what their patients think about treatment adherence, and to compare the gynecologists' opinions with the patients' own perceptions within the CRETA study.Spanish gynecologists who ...
María Jesús Cancelo Hidalgo +8 more
openalex +4 more sources
Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy [PDF]
International Journal of Women's Health, 2013 Several recent, large-scale studies have provided valuable insights into patient perspectives on postmenopausal vulvovaginal health. Symptoms of vulvovaginal atrophy, which include dryness, irritation, itching, dysuria, and dyspareunia, can adversely affect interpersonal relationships, quality of life, and sexual function.
Parish SJ +6 more
openalex +7 more sources
The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause [PDF]
Climacteric, 2018 Objectives: The primary objective of the European Vulvovaginal Epidemiological Survey (EVES) was to assess, at a country level, the prevalence of postmenopausal women with vulvovaginal atrophy (VVA) confirmed by gynecological clinical assessment among all postmenopausal women attending menopause centers.
Santiago Palacios +4 more
openalex +5 more sources
Mayo Clinic Proceedings, 2010 Vulvovaginal atrophy (VVA) is a common and underreported condition associated with decreased estrogenization of the vaginal tissue. Symptoms include dryness, irritation, soreness, and dyspareunia with urinary frequency, urgency, and urge incontinence. It can occur at any time in a woman's life cycle, although more commonly in the postmenopausal phase ...
Maire B, Mac Bride +2 more
openaire +3 more sources
Lubricants application in vulvovaginal atrophy
Russian Journal of Woman and Child Health, 2018 Lubricants application in vulvovaginal atrophy Yu.E. Dobrokhotova, S.A. Khlynova Pirogov Russian National Research Medical University, Moscow, Russian Federation Interim periods as well as the postmenopausal period are extremely important in relation to the development of the disease and the complications associated with estrogen deficiency. Although
Yu.E. Dobrokhotova, S. А. Khlynova
openalex +3 more sources
Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
Gynecological Endocrinology, 2021 It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VVA) related to menopause. Equally, young women may temporarily present this clinical problem while receiving various pharmacological or endocrine treatments or radiotherapy.To determine clinical and diagnostic exams required to confirm the presence of VVA (also ...
Faustino R. Pérez-López +5 more
openaire +3 more sources